Your browser doesn't support javascript.
loading
A risk stratification scheme for selection of a glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention based on clinical and angiographic criteria.
Kini, A S; Reich, D; Mitre, C A; Sharma, S K.
Affiliation
  • Kini AS; Cardiac Catheterization Laboratory, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA.
Am J Cardiol ; 88(11): 1287-90, 2001 Dec 01.
Article in En | MEDLINE | ID: mdl-11728356
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Tyrosine / Immunoglobulin Fab Fragments / Angioplasty, Balloon, Coronary / Coronary Angiography / Platelet Glycoprotein GPIIb-IIIa Complex / Antibodies, Monoclonal Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Cardiol Year: 2001 Document type: Article Affiliation country: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Tyrosine / Immunoglobulin Fab Fragments / Angioplasty, Balloon, Coronary / Coronary Angiography / Platelet Glycoprotein GPIIb-IIIa Complex / Antibodies, Monoclonal Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Cardiol Year: 2001 Document type: Article Affiliation country: Estados Unidos